Cargando…
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Three long-acting muscarinic antagonists (LAMAs) are now available in Europe, providing clinicians and patients with a choice of interventions, which is important in COPD, which is clinically a heterogeneous disease. The first LAMA, tiotropium, has been widely used over the last decade as a once-dai...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381904/ https://www.ncbi.nlm.nih.gov/pubmed/25848244 http://dx.doi.org/10.2147/COPD.S76520 |